News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ranbaxy Laboratories (RANBAXY.BO) Rumored to Cut One-Third of Global Sales Force, Mainly in U.S.: Source


5/23/2013 6:48:17 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Even as trouble thickens for drug maker Ranbaxy Laboratories, the company is now considering downsizing its global sales force by around a third. A majority of the job cuts would be in the US, it is learnt. “Ranbaxy is planning to lay off field force globally… mainly in the US. The company was contemplating this for some time, especially in view of the issues there. The business has suffered because of regulatory issues through past years. Besides, it also had to incur additional costs to settle those issues,” an industry source told Business Standard. An email query sent to Ranbaxy did not elicit any response. According to a company official who did not wish to be named, Ranbaxy’s current global field force stands at around 14,600, of which 5,000-5,200 are in India.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES